p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis

p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis

<b>Importance</b>: The protein p53 is an unequivocal tumor suppressor that is altered in half of all cancers. The immune system produces systemic p53 autoantibodies (p53 Abs) in many cancer patients. <b>Objective</b>: This systemic review and meta-analysis focuses on the prog...

Full description

Bibliographic Details
Main Authors:	Navid Sobhani, Giandomenico Roviello, Alberto D’Angelo, Raheleh Roudi, Praveen Kumar Neeli, Daniele Generali
Format:	Article
Language:	English
Published:	MDPI AG 2021-10-01
Series:	Molecules
Subjects:	meta-analysis p53 serum p53 antibodies cancer survival prognostic biomarker
Online Access:	https://www.mdpi.com/1420-3049/26/20/6215

Similar Items

Detection of p53 mutation and serum monitoring alert caused by Marek’s disease virus in poultry
by: Huixia Zhang, et al.
Published: (2020-08-01)

Sera Anti-P53 Antibody Provides New Information Which Explains the Link Between Diabetes and Cancer
by: Sauriasari R, et al.
Published: (2020-02-01)

Immunohistochemical analysis of P53 and its correlation to the other prognostic factors in breast cancer
by: "Etebary M, et al.
Published: (2002-06-01)

Immunohistochemical analysis of P53 and its correlation to the other prognostic factors in breast cancer
by: "Etebary M, et al.
Published: (2002-06-01)

Novel Monoclonal Antibodies Specific for Human Ki67 and P53 Tumor Markers in Breast Cancer Tissue Samples
by: Masoud Hassanzadeh Makoui, et al.
Published: (2023-06-01)

Che-1/AATF: a critical co-factor for both wild type- and mutant-p53 proteins
by: Tiziana eBruno, et al.
Published: (2016-02-01)

P53 mRNA in- Situ Hybridization analysis and Immunohistochemical Expression in Lung Cancer: A Comparative Study.
by: Ban A. Abdul-Majeed
Published: (2010-10-01)

Histopathology and Prognostic Indices of Carcinoma Breast with Special Reference to p53 Marker
by: Rajesh Kanna Nandagopal Radha, et al.
Published: (2014-07-01)

Serum p53 antibody detection in patients with impaired lung function
by: Mattioni Manlio, et al.
Published: (2013-02-01)

Pyrimidine Triones as Potential Activators of p53 Mutants
by: Maryam M. Jebril Fallatah, et al.
Published: (2024-08-01)

The Status of p53 Oligomeric and Aggregation States in Cancer
by: Guilherme A. P. de Oliveira, et al.
Published: (2020-04-01)

The TP53 fertility network
by: Diego d'Avila Paskulin, et al.
Published: (2012-01-01)

Regulation of p53 Function by Formation of Non-Nuclear Heterologous Protein Complexes
by: Lev Zavileyskiy, et al.
Published: (2022-02-01)

p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations
by: You-Na Sung, et al.
Published: (2022-12-01)

Depletion of R270C Mutant p53 in Osteosarcoma Attenuates Cell Growth but Does Not Prevent Invasion and Metastasis In Vivo
by: Takatsune Shimizu, et al.
Published: (2022-11-01)

Anti-p53 autoantibody as early diagnostic and prognostic marker of bronchogenic carcinoma in smokers
by: Mohammed B.M Sofyan, et al.
Published: (2018-01-01)

Recent Synthetic Approaches towards Small Molecule Reactivators of p53
by: Jerson L. Silva, et al.
Published: (2020-04-01)

Hubungan Ekspresi p53 dengan Prognosis Hasil Terapi Radiasi pada Karsinoma Nasofaring
by: Ario Tejosukmono, et al.
Published: (2016-02-01)

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease
by: Giulia Abate, et al.
Published: (2020-12-01)

Searching for a cut-off point for p53 immunohistochemistry as evidence of TP53 mutations
by: Ilay Caliskan, et al.
Published: (2024-03-01)

The Investigation of WRAP53 rs2287499 Association with Thyroid Cancer Risk and Prognosis among the Azeri Population in Northwest Iran
by: Esmaeil Darvish Aminabad, et al.
Published: (2017-11-01)

TP53 drives invasion through expression of its Δ133p53β variant
by: Gilles Gadea, et al.
Published: (2016-09-01)

Chemical Variations on the p53 Reactivation Theme
by: Carlos J. A. Ribeiro, et al.
Published: (2016-05-01)

p53/Surviving Ratio as a Parameter for Chemotherapy Induction Response in Children with Acute Myeloid Leukemia
by: Rinaldi Lenggana, et al.
Published: (2016-11-01)

Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
by: Shengliang Zhang, et al.
Published: (2022-04-01)

Recent findings on the role of wild-type and mutant p53 in cancer development and therapy
by: Mehregan Babamohamadi, et al.
Published: (2022-09-01)

Opposing Roles of Wild-type and Mutant p53 in the Process of Epithelial to Mesenchymal Transition
by: Oleg Semenov, et al.
Published: (2022-06-01)

Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
by: Dafei Chai, et al.
Published: (2024-06-01)

C-Terminal p53 Palindromic Tetrapeptide Restores Full Apoptotic Function to Mutant p53 Cancer Cells In Vitro and In Vivo
by: Robert L. Fine, et al.
Published: (2023-01-01)

Heterogeneity of TP53 Mutations and P53 Protein Residual Function in Cancer: Does It Matter?
by: Paola Monti, et al.
Published: (2020-10-01)

Impact of RUNX2 on drug-resistant human pancreatic cancer cells with p53 mutations
by: Toshinori Ozaki, et al.
Published: (2018-03-01)

Serum NY‐ESO‐1 and p53 antibodies as useful tumor markers in gastric cancer
by: Junji Kawada, et al.
Published: (2024-03-01)

Regulation of Energy Metabolism: An Important Facet of P53 Function
by: Marc Gilbert, et al.
Published: (2017-06-01)

Immunohistochemical detection of p53 and pp53 Ser392 in canine hemangiomas and hemangiosarcomas located in the skin
by: María José García-Iglesias, et al.
Published: (2020-07-01)

Twenty years of Gendicine® rAd-p53 cancer gene therapy: The first-in-class human cancer gene therapy in the era of personalized oncology
by: Li Qi, et al.
Published: (2024-07-01)

Neoplasias astrocitárias e correlação com as proteínas p53 mutada e Ki-67 Astrocytic neoplasms and correlation with mutate p53 and Ki-67 proteins
by: Gustavo Rassier Isolan, et al.
Published: (2005-12-01)

Expression of Ki 67 and P53 immunohistochemical markers in central nervous system astrocytoma
by: Mahmood Sh. Mahmood, et al.
Published: (2015-01-01)

Therapeutic Strategies to Activate p53
by: Angelo Aguilar, et al.
Published: (2022-12-01)

Unraveling the Role of TP53 in Colorectal Cancer Therapy: From Wild-Type Regulation to Mutant
by: Wenshu Li, et al.
Published: (2024-07-01)

Imunorreatividade da p53 associada à ausência de mutações no gene TP53 em linfomas caninos Immunostaing of p53 associated with absence of mutations in TP53 gene in dogs with lymphoma
by: Sabryna Gouveia Calazans, et al.
Published: (2010-06-01)